Raymond James & Associates Accolade, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Accolade, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 26,970 shares of ACCD stock, worth $93,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,970
Previous 26,192
2.97%
Holding current value
$93,585
Previous $93,000
10.75%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ACCD
# of Institutions
171Shares Held
67.6MCall Options Held
181KPut Options Held
1.66M-
Black Rock Inc. New York, NY6.16MShares$21.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.38MShares$18.7 Million0.2% of portfolio
-
Brown Advisory Inc4.82MShares$16.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$14.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.99MShares$13.8 Million0.01% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $250M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...